A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
Clinical trial NCT05951959 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05951959
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2028-10-31
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.